General Information of Drug (ID: DMS7POY)

Drug Name
4-(2,4-dichlorophenoxy)-3-hydroxybenzonitrile
Synonyms Triclosan derivative, 4; SCHEMBL3365482; CHEMBL260168; BDBM25403; QYLRCMQANMWAOJ-UHFFFAOYSA-N; ZINC29059641; 4-(2,4-dichlorophenoxy)-3-hydroxy-benzonitrile; hydroxybenzonitrile (19)
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 280.1
Logarithm of the Partition Coefficient (xlogp) 4.1
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C13H7Cl2NO2
IUPAC Name
4-(2,4-dichlorophenoxy)-3-hydroxybenzonitrile
Canonical SMILES
C1=CC(=C(C=C1C#N)O)OC2=C(C=C(C=C2)Cl)Cl
InChI
InChI=1S/C13H7Cl2NO2/c14-9-2-4-12(10(15)6-9)18-13-3-1-8(7-16)5-11(13)17/h1-6,17H
InChIKey
QYLRCMQANMWAOJ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
25023955
TTD ID
D0U7MR

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Plasmodium Enoyl-ACP reductase (Malaria fabI) TTNX2CS Q965D5_PLAFA Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalar... J Biol Chem. 2007 Aug 31;282(35):25436-44.